Have you been diagnosed with migraine? Are you currently pregnant? If so, you may be able to take part in a United States pregnancy registry.
This registry has been created to help doctors better understand if Aimovig® (erenumab-aooe) has any effect on a woman’s pregnancy, delivery, or baby. However, you do not have to have taken Aimovig to participate.
If you are currently pregnant and taking Aimovig, contact your healthcare provider. They will help you decide if you should stop taking Aimovig.
Get more info on the registryFill out the contact form to have a registry representative contact you with more information about this pregnancy registry.
Call the registry’s toll-free number
1 (833) 244-4083 and speak to a registry representative.
Ask your healthcare provider to help you complete the contact form.
Pregnancy registries are designed to help us learn more about the effects of a medication when taken by a pregnant woman. These registries gather information on the pregnant woman and her baby, both before and after the baby is born. Registries are important because pregnant women are often not included in the clinical studies that investigate medications before they are approved.
By enrolling in a pregnancy registry, you can help improve safety information for medicines, which enables informed decision-making by healthcare providers and pregnant women in the future.
For the latest important safety information, please refer to the full Prescribing Information and Patient Information. This is not intended to replace discussions with your healthcare provider.